Evidence map›Paper›PMID 31185022›Full record

ArticlePloS one2019

Computational modeling of retinal hypoxia and photoreceptor degeneration in patients with age-related macular degeneration.

Kevin J McHugh, Dian Li, Jay C Wang, Leon Kwark, Jessica Loo, Venkata Macha, Sina Farsiu, Leo A Kim, Magali Saint-Geniez

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Kevin J McHughSchepens Eye Research Institute, Massachusetts Eye and Ear, Boston, MA, United States of America.ORCID 0000-0001-6801-4431
Dian LiSchepens Eye Research Institute, Massachusetts Eye and Ear, Boston, MA, United States of America.ORCID 0000-0002-5374-7314
Jay C WangDepartment of Ophthalmology, Harvard Medical School, Boston, MA, United States of America.
Leon KwarkDepartments of Ophthalmology and Biomedical Engineering, Duke University, Durham, NC, United States of America.
Jessica LooDepartments of Ophthalmology and Biomedical Engineering, Duke University, Durham, NC, United States of America.
Venkata MachaDepartment of Computer Science, Harvard College, Cambridge, MA, United States of America.
Sina FarsiuDepartments of Ophthalmology and Biomedical Engineering, Duke University, Durham, NC, United States of America.
Leo A KimSchepens Eye Research Institute, Massachusetts Eye and Ear, Boston, MA, United States of America.
Magali Saint-GeniezSchepens Eye Research Institute, Massachusetts Eye and Ear, Boston, MA, United States of America.ORCID 0000-0001-9897-138X
Duke University · USMassachusetts Eye and Ear Infirmary · USBoston University · USHarvard University · US

Funding

VISION RESEARCHP30EY003790 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI Sunil K Chauhan · 1985 to 2026
$25.5M
VISION RESEARCHP30EY005722 · NEI · DUKE UNIVERSITY · PI Vadim Y Arshavsky · 1985 to 2026
$19.3M
Mass Eye and Ear-Vision Clinical Scientist Development ProgramK12EY016335 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI Reza Dana · 2004 to 2026
$12.3M
Bioengineering of Bruch's Membrane for the treatment of Age-related Macular DegenDP2OD006649 · OD · SCHEPENS EYE RESEARCH INSTITUTE · PI SAINT-GENIEZ, MAGALI · 2009 to 2009
$2.9M
Role of Runx1 in Pathologic Ocular AngiogenesisR01EY027739 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI KIM, LEO A · 2018 to 2022
$2.8M
NEI NIH HHS K12 EY016335NEI NIH HHS P30 EY003790NEI NIH HHS P30 EY005722NEI NIH HHS R01 EY027739NIH HHS DP2 OD006649
6 · The paper itself

Abstract

Although drusen have long been acknowledged as a primary hallmark of dry age-related macular degeneration (AMD) their role in the disease remains unclear. We hypothesize that drusen accumulation increases the barrier to metabolite transport ultimately resulting in photoreceptor cell death. To investigate this hypothesis, a computational model was developed to evaluate steady-state oxygen distribution in the retina. Optical coherence tomography images from fifteen AMD patients and six control subjects were segmented and translated into 3D in silico representations of retinal morphology. A finite element model was then used to determine the steady-state oxygen distribution throughout the retina for both generic and patient-specific retinal morphology. Oxygen levels were compared to the change in retinal thickness at a later time point to observe possible correlations. The generic finite element model of oxygen concentration in the retina agreed closely with both experimental measurements from literature and clinical observations, including the minimal pathological drusen size identified by AREDS (64 μm). Modeling oxygen distribution in the outer retina of AMD patients showed a substantially stronger correlation between hypoxia and future retinal thinning (Pearson correlation coefficient, r = 0.2162) than between drusen height and retinal thinning (r = 0.0303) indicating the potential value of this physiology-based approach. This study presents proof-of-concept for the potential utility of finite element modeling in evaluating retinal health and also suggests a potential link between transport and AMD pathogenesis. This strategy may prove useful as a prognostic tool for predicting the clinical risk of AMD progression.

Indexed as

AgedAged, 80 and overCase-Control StudiesCell HypoxiaComputer SimulationFemaleFinite Element AnalysisHumansImage Processing, Computer-AssistedMacular DegenerationMaleOxygenProof of Concept StudyRetinaTomography, Optical CoherenceOxygen

Identifiers

PMID31185022
PMCPMC6559637
OpenAlexW2949624174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.